Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares traded down 6% on Tuesday after Mizuho lowered their price target on the stock from $52.00 to $50.00. The stock traded as low as $26.42 and last traded at $26.45. 626,594 shares traded hands during mid-day trading, a decline of 31% from the average session volume of […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter. Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) last posted its quarterly earnings data on Monday, March 13th. The company reported ($0.65) […]
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) is one of 994 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Amylyx Pharmaceuticals to related companies based on the strength of its institutional ownership, profitability, risk, valuation, analyst recommendations, earnings and dividends. Analyst Ratings This is a summary […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) insider Patrick D. Yeramian sold 49,579 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $30.54, for a total value of $1,514,142.66. Following the completion of the sale, the insider now owns 208,417 shares […]